Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.brawnbiotech.com | |
Market Cap | 6.56 Cr. | |
Enterprise Value(EV) | 6.56 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -3.90 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-06 |
Industry PE | 38.26 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 20.46 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 1.07 | Calculated using Price: 21.85 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.30 Cr. | 3,000,300 Shares |
FaceValue | 10 | |
About Brawn Biotech Ltd. | ||
Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company's loan license basis. The company is located in New Delhi, India. |
1 Day |
|
|
1 Week |
|
-5.00% |
1 Month |
|
-8.65% |
3 Month |
|
+31.86% |
6 Month |
|
+25.79% |
1 Year |
|
+24.86% |
2 Year |
|
+7.11% |
5 Year |
|
-48.77% |
10 Year |
|
+187.50% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 3.14 | 5.91 | 18.15 | 22.39 | 17.62 | 16.37 | 6.60 | -6.10 | -20.53 | |
Return on Capital Employed (%) | 8.07 | 11.98 | 26.39 | 29.04 | 27.75 | 23.03 | 9.74 | -3.57 | -25.66 | |
Return on Assets (%) | 1.06 | 2.05 | 6.80 | 9.01 | 6.49 | 5.93 | 2.77 | -3.24 | -12.23 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 5 | 5 | 6 | 7 | 8 | 9 | 9 | 9 | 7 | 6 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 9 | 9 | 8 | 10 | 15 | 14 | 11 | 5 | 6 | 8 | |
Minority Int. | |||||||||||
Equity & Liab. | 14 | 14 | 14 | 17 | 22 | 22 | 20 | 14 | 13 | 14 | |
Non Curr. Assets | 3 | 3 | 3 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |
Curr. Assets | 11 | 11 | 11 | 17 | 22 | 22 | 19 | 13 | 12 | 13 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 14 | 14 | 14 | 17 | 22 | 22 | 20 | 14 | 13 | 14 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 38 | 39 | 47 | 61 | 56 | 65 | 50 | 35 | 9 | 26 | |
Other Income | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | ||
Total Income | 38 | 39 | 47 | 61 | 56 | 66 | 50 | 35 | 9 | 26 | |
Total Expenditure | -37 | -38 | -45 | -59 | -54 | -64 | -49 | -36 | -11 | -27 | |
PBIDT | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 0 | -2 | -1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | -1 | ||||||||||
PAT | 0 | 0 | 1 | 1 | 1 | 1 | 1 | -1 | -2 | -1 | |
Adjusted EPS | 0 | 1 | 3 | 5 | 4 | 4 | 2 | -2 | -5 | -4 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 1 | -2 | 0 | 0 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Net Change | 0 | 0 | 0 | 0 | 2 | -2 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 |
Fri, 29 Sep 2023
Closure of Trading Window CLOSURE OF TRADING WINDOW FOR THE QUARETER ENDING 30TH SEPTEMBER 2023. |
Fri, 29 Sep 2023
Closure of Trading Window CLOSURE OF TRADING WINDOW FOR THE QUARETER ENDING 30TH SEPTEMBER 2023. |
Tue, 26 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Scrutinizer Report along with Voting results attached. |
Tue, 03 Oct 2023 |
|
|
|
|
|